Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide in Painful Distal Diabetic Neuropathy
NCT00135109Phase 3Completed
- Sponsor
- UCB
- Start
- Oct 2004
- Primary completion
- Dec 2005
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lacosamide in diabetic neuropathy (4 arms), sponsored by UCB. Primary endpoint: Average Daily Pain Intensity at 18 weeks. Started Oct 2004; status: completed.
02
Drugs
lacosamide
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT00135109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00135109.